| 证券代码 | AMRHW.O |
| 证券名称 | Ameri Holdings Inc Wt |
| 证券类型 | 美国权证 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2017-11-17 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | - |
| 公司名称 | Enveric Biosciences, Inc. |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 100 Canal Pointe Blvd., Suite 108 Princeton, New Jersey, USA |
| 成立日期 | 1994-02 |
| 董事会主席 | - |
| 公司属地 | United States 美国 |
| 公司网址 | www.ameri100.com |
| 电话 | +1 (732) 243-9250 |
| 传真 | - |
| 公司简介 | Enveric Biosciences, Inc. (Formerly: Ameri Holdings, Inc.) specializes in delivering SAP cloud, digital and enterprise services to clients worldwide. SAP is a leader in providing enterprise resource planning (“ERP”) software and technologies to enterprise customers worldwide. The company delivers a wide range of solutions and services across multiple domains and industries. Its services center around SAP and include technology consulting, business intelligence, cloud services, application development/integration and maintenance, implementation services, infrastructure services, and independent validation services, all of which can be delivered as a set of managed services or on an on-demand service basis, or a combination of both. On August 12, 2020, Ameri, Jay Pharma and certain other signatories thereto signed Tender Offer Support Agreement and Termination of Amalgamation Agreement. Upon completion of the Spin-Off and the Offer, Ameri will change its name to Enveric Biosciences, Inc. |